Big Pharma markets left on a ‘patent cliff’-h...

US and Chinese experts meet to discuss mitigating AI risks despite an ongoing tech rivalry, and US megadonors are largely backing Republicans in this midterm election season. Plus, Prime Minister Mark Carney strikes out on his pitch for a “unique alliance” between Canada and the ...  Show more

Tech stocks fell yesterday as markets reacted to ongoing talk of an AI apocalypse, industrial America is contending with a fresh wave of supply chain inflation, and foreign investors are now buying more US stocks than government bonds. Plus, China has implemented sweeping new con ...  Show more

India could soon see its largest-ever pharma deal as the 10th biggest pharma company by revenues -- Torrent -- is trying to buy the fourth largest one -- Cipla. But, is the bullet too big to bite for Torrent? Is the funding feasible? Will the compatibility not of portfolio but ...

India's primary market is set to witness back-to-back billion-dollar IPOs, including Hyundai's record-breaking Rs 25,000 crore issue. With heavyweights like Swiggy and Afcons Infrastructure also preparing to go public, investors are closely watching the potential market impact. W ...  Show more

Zee's diverse content and Sony's global muscle promised a Bollywood blockbuster of a merger. But the highly romanticised story takes a dramatic turn! Rumours are swirling that the $10 billion mega-merger might be off. What are the hurdles? And what went wrong in the two years? ...

Endo Pharmaceuticals and its attorneys at Arnold & Porter are facing accusations of serious discovery misconduct during opioid litigation across the country, threatening the company with huge liability and the lawyers with reputational damage. On this week’s show, we break down t ...  Show more